One hundred patients with bilateral age-related cataract ( 200 eyes ) had standard cataract surgery with implantation of an iMics1 NY-60 IOL ( Hoya Corp ) in one eye and an AcrySof SN60WF IOL ( Alcon Laboratories ) in the other eye .
